ARTICLE | Clinical News
Fabrazyme agalsidase beta regulatory update
July 18, 2005 7:00 AM UTC
CHMP issued a positive opinion recommending approval to add additional clinical efficacy evidence to Fabrazyme's labeling. The changes will include results from a trial that showed that the rate of cl...